Exchange: NASDAQ·Updated 11:43 AM EDT
FTRE logo

FTRE Fortrea Holdings Inc. Common Stock

$18.15
$0.66
(3.51%)
Today
EarningsNov 5
Mkt Cap$1.79B
Vol250,006.00

About FTRE

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.
49

Neutral Sentiment

How do you feel about FTRE?

Advertisement|Remove ads.